$2.920
-0.106 (-3.63%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ABOS Prediction & Forecast by Similar Chart Analysis
Alphio's ABOS stock price prediction model matches the current Acumen Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.89 (-1.15%). The 1-week path is $2.93 (+0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Acumen Pharmaceuticals Inc Stock?
Acumen Pharmaceuticals Inc (ABOS) is a good buy right now due to its current price of $2.92, which is significantly lower than the analyst price target of $8, suggesting a potential upside of over 173%. Additionally, the company has shown a positive trend with a year-to-date change of +44.55%, and despite recent losses, it has reduced its Q2 net loss to $32.72 million from $40.95 million last year, indicating improved financial management. The main risk is the negative earnings per share (EPS) of -0.45 reported for Q2 2026, which reflects ongoing financial challenges.
ABOS stock price ended at $2.92 on Friday, after losing -3.63%
Acumen Pharmaceuticals Inc (ABOS) last closed at $2.92, losing -3.63%. These facts feed the 1-day and 1-week ABOS price prediction above.
Forecast Drivers
Acumen Pharmaceuticals Inc (ABOS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ABOS, ranked by similarity.
Seasonality analysis for ABOS
Historically the probability of a positive August return for ABOS is 31.75%. March offers the highest probability of a positive month at 52.38%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ABOS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.77 | $1.81 | $1.96 | -37.97% |
| Sep 2026 | $1.41 | $1.55 | $1.65 | -47.04% |
| Oct 2026 | $1.66 | $1.71 | $2.00 | -41.45% |
| Nov 2026 | $1.17 | $1.41 | $1.48 | -51.87% |
| Dec 2026 | $1.39 | $1.52 | $1.62 | -48.02% |
In 2026, Acumen Pharmaceuticals Inc (ABOS) is projected to range from $1.17 to $2.00.
Acumen Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Acumen Pharmaceuticals Inc is projected to average $1.81, with a low of $1.77 and high of $1.96.
In Sep 2026, Acumen Pharmaceuticals Inc is projected to average $1.55, with a low of $1.41 and high of $1.65.
In Oct 2026, Acumen Pharmaceuticals Inc is projected to average $1.71, with a low of $1.66 and high of $2.00.
In Nov 2026, Acumen Pharmaceuticals Inc is projected to average $1.41, with a low of $1.17 and high of $1.48.
In Dec 2026, Acumen Pharmaceuticals Inc is projected to average $1.52, with a low of $1.39 and high of $1.62.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。